Role of oral microbiota in Alzheimer’s disease: A systematic review of clinical studies

Qiujun Piao

doi:10.54254/2753-8818/8/20240388

Research Article

Open access

Published on 13 November 2023

Download pdf

Piao,Q. (2023). Role of oral microbiota in Alzheimer’s disease: A systematic review of clinical studies. Theoretical and Natural Science,8,200-213.

Export citation

Role of oral microbiota in Alzheimer’s disease: A systematic review of clinical studies

Qiujun Piao *^,1,

¹ Oxford International College

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/8/20240388

Abstract

Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases in the world, causing dementia among the elderly. Oral microbiome may be associated with AD. This systematic review summarizes the current role of the oral microbiome in the etiology and diagnosis of AD. Articles included were sourced primarily from electronic databases including PubMed, EMBASE, Web of Science, Scopus, and Cochrane Library from January 2011 to August 2022 and in OpenGrey and Google Scholar for grey literature. Relevant studies were selected using a two-stage approach involving the screening of titles and abstracts and full-text evaluation by two authors. Risk of bias was also performed using the Newcastle Ottawa scale (NOS) before qualitative synthesis. 18 studies out of 1079 citations were included in this review. The median NOS rating (IQR) of the reviewed studies was 8 (7.25 – 9). Most studies suggested that there was an association between oral microbiome and AD. Some claimed that oral microbiome might be the risk factor of AD using disparate approaches. Others also detected antibodies to oral microorganisms among AD patients and observed a significantly different alpha diversity among patients with AD than controls. Although limited by the number of studies, this review found that a change in the oral microbiome may be indicative of AD severity. Oral microbiome may be associated with Alzheimer’s disease. Some microbial species may be risk factors or aid diagnosis for AD, however more research is still needed to establish their role in AD etiology and noninvasive diagnosis.

Keywords

Alzheimer’S Disease, Oral Microbiome

View pdf

References

[1]. Jack Jr CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimer's & Dementia. 2018;14(4):535-62.

[2]. Nichols E, Vos T. The estimation of the global prevalence of dementia from 1990‐2019 and forecasted prevalence through 2050: An analysis for the Global Burden of Disease (GBD) study 2019. Alzheimer's & Dementia. 2021;17:e051496.

[3]. Association As, Thies W, Bleiler L. 2013 Alzheimer's disease facts and figures. Alzheimer's & dementia. 2013;9(2):208-45.

[4]. Burgio L. Interventions for the behavioral complications of Alzheimer's disease: behavioral approaches. International Psychogeriatrics. 1996;8(S1):45-52.

[5]. Armstrong RA. Risk factors for Alzheimer’s disease. Folia neuropathologica. 2019;57(2):87-105.

[6]. Silva MVF, Loures CdMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MdG. Alzheimer’s disease: risk factors and potentially protective measures. Journal of biomedical science. 2019;26(1):1-11.

[7]. Luchsinger JA, Mayeux R. Cardiovascular risk factors and Alzheimer’s disease. Current Atherosclerosis Reports. 2004;6(4):261-6.

[8]. Exley C. Aluminum Should Now Be Considered a Primary Etiological Factor in Alzheimer’s Disease. Journal of Alzheimer's Disease Reports. 2017;1:23-5.

[9]. Kawahara M, Kato-Negishi M. Link between aluminum and the pathogenesis of Alzheimer's disease: the integration of the aluminum and amyloid cascade hypotheses. International journal of Alzheimer’s disease. 2011;2011.

[10]. Akiyama H, Hosokawa M, Kametani F, Kondo H, Chiba M, Fukushima M, et al. Long‐term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AβPP and AβPP/tau transgenic mice. Neuropathology. 2012;32(4):390-7.

[11]. Sparks D, Friedland R, Petanceska S, Schreurs B, Shi J, Perry G, et al. Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology. The journal of nutrition, health & aging. 2006;10(4):247.

[12]. Kivipelto M, Helkala E-L, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Bmj. 2001;322(7300):1447-51.

[13]. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. Jama. 1995;274(23):1846-51.

[14]. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk Factors for Alzheimer’s Disease: A Prospective Analysis from the Canadian Study of Health and Aging. American Journal of Epidemiology. 2002;156(5):445-53.

[15]. Cui Y, Dai S, Miao Z, Zhong Y, Liu Y, Liu L, et al. Reliability and validity of the Chinese version of the mild behavioral impairment checklist for screening for Alzheimer’s disease. Journal of Alzheimer's Disease. 2019;70(3):747-56.

[16]. van Oostveen WM, de Lange EC. Imaging techniques in Alzheimer’s disease: a review of applications in early diagnosis and longitudinal monitoring. International journal of molecular sciences. 2021;22(4):2110.

[17]. Davies H, Wathen C, Gleeson F. The risks of radiation exposure related to diagnostic imaging and how to minimise them. Bmj. 2011;342.

[18]. Rehani MM, Berry M. Radiation doses in computed tomography: the increasing doses of radiation need to be controlled. British Medical Journal Publishing Group; 2000. p. 593-4.

[19]. Zamrini E, De Santi S, Tolar M. Imaging is superior to cognitive testing for early diagnosis of Alzheimer’s disease. Neurobiology of Aging. 2004;25(5):685-91.

[20]. Blennow K, Zetterberg H. Biomarkers for Alzheimer's disease: current status and prospects for the future. Journal of Internal Medicine. 2018;284(6):643-63.

[21]. Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, et al. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. The Lancet Neurology. 2021;20(6):484-96.

[22]. Hölttä M, Hansson O, Andreasson U, Hertze J, Minthon L, Nägga K, et al. Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease. PLOS ONE. 2013;8(6):e66381.

[23]. Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Science advances. 2019;5(1):eaau3333.

[24]. Kumar PS. From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease. The Journal of Physiology. 2017;595(2):465-76.

[25]. Pritchard AB, Crean S, Olsen I, Singhrao SK. Periodontitis, microbiomes and their role in Alzheimer’s disease. Frontiers in aging neuroscience. 2017;9:336.

[26]. Shoemark DK, Allen SJ. The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease. Journal of Alzheimer's Disease. 2015;43(3):725-38.

[27]. Emery DC, Cerajewska TL, Seong J, Davies M, Paterson A, Allen-Birt SJ, et al. Comparison of Blood Bacterial Communities in Periodontal Health and Periodontal Disease. Front Cell Infect Microbiol. 2021;10:15.

[28]. Kamer AR, Pushalkar S, Gulivindala D, Butler T, Li Y, Annam KRC, et al. Periodontal dysbiosis associates with reduced CSF A beta 42 in cognitively normal elderly. Alzheimers Dement-Diagn Assess Dis Monit. 2021;13(1):9.

[29]. Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean S. Determining the Presence of Periodontopathic Virulence Factors in Short-Term Postmortem Alzheimer's Disease Brain Tissue. J Alzheimers Dis. 2013;36(4):665-77.

[30]. Romeo MA, Gilardini Montani MS, Gaeta A, D'Orazi G, Faggioni A, Cirone M. HHV-6A infection dysregulates autophagy/UPR interplay increasing beta amyloid production and tau phosphorylation in astrocytoma cells as well as in primary neurons, possible molecular mechanisms linking viral infection to Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis. 2020;1866(3):165647.

[31]. Ashton NJ, Ide M, Zetterberg H, Blennow K. Salivary biomarkers for Alzheimer’s disease and related disorders. Neurology and Therapy. 2019;8(2):83-94.

[32]. Reale M, Gonzales-Portillo I, Borlongan CV. Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: Present and future applications. Brain research. 2020;1727:146535.

[33]. Sansores-España LD, Morales F, Arriola-Pacheco F, Astorga J, Paula-Lima A, Carrillo-Ávila A, et al. Gingival crevicular fluid as Biomarker’s source for alzheimer’s disease. Odovtos-International Journal of Dental Sciences. 2022;24(1):156-76.

[34]. Selçuk AA. A guide for systematic reviews: PRISMA. Turkish archives of otorhinolaryngology. 2019;57(1):57.

[35]. Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, et al. 16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain. Front Aging Neurosci. 2017;9:13.

[36]. Fu KL, Chiu MJ, Wara-Aswapati N, Yang CN, Chang LC, Guo YL, et al. Oral microbiome and serological analyses on association of Alzheimer's disease and periodontitis. Oral Dis. 2022.

[37]. Moghadam MT, Amirmozafari N, Mojtahedi A, Bakhshayesh B, Shariati A, Jazi FM. Association of perturbation of oral bacterial with incident of Alzheimer's disease: A pilot study. J Clin Lab Anal. 2022;36(7):11.

[38]. Sansores-Espana LD, Morales F, Arriola-Pacheco F, Astorga J, Paula-Lima A, Carrillo-Avila A, et al. Gingival Crevicular Fluid as Biomarker's Source for Alzheimer's Disease. Odovtos Int J Dent Sci. 2022;24(1):156-76.

[39]. Yang B, Tao BB, Yin QY, Chai ZW, Xu L, Zhao QH, et al. Associations Between Oral Health Status, Perceived Stress, and Neuropsychiatric Symptoms Among Community Individuals With Alzheimer's Disease: A Mediation Analysis. Front Aging Neurosci. 2022;13:14.

[40]. Cirstea MS, Kliger D, MacLellan AD, Yu AC, Langlois J, Fan MN, et al. The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's Disease. J Alzheimers Dis. 2022;87(1):247-58.

[41]. Guo HY, Li BA, Yao HT, Liu DF, Chen RR, Zhou SH, et al. Profiling the oral microbiomes in patients with Alzheimer's disease. Oral Dis.15.

[42]. Liu XX, Jiao B, Liao XX, Guo LN, Yuan ZH, Wang X, et al. Analysis of Salivary Microbiome in Patients with Alzheimer's Disease. J Alzheimers Dis. 2019;72(2):633-40.

[43]. Ide M, Harris M, Stevens A, Sussams R, Hopkins V, Culliford D, et al. Periodontitis and Cognitive Decline in Alzheimer's Disease. PLoS One. 2016;11(3):9.

[44]. Noble JM, Scarmeas N, Celenti RS, Elkind MSV, Wright CB, Schupf N, et al. Serum IgG Antibody Levels to Periodontal Microbiota Are Associated with Incident Alzheimer Disease. PLoS One. 2014;9(12):14.

[45]. Stein PS, Steffen MJ, Smith C, Jicha G, Ebersole JL, Abner E, et al. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement. 2012;8(3):196-203.

[46]. Wu YF, Lee WF, Salamanca E, Yao WL, Su JN, Wang SY, et al. Oral Microbiota Changes in Elderly Patients, an Indicator of Alzheimer's Disease. Int J Environ Res Public Health. 2021;18(8):14.

[47]. Leblhuber F, Huemer J, Steiner K, Gostner JM, Fuchs D. Knock-on effect of periodontitis to the pathogenesis of Alzheimer's disease? Wien Klin Wochen. 2020;132(17-18):493-8.

[48]. Holmer J, Aho V, Eriksdotter M, Paulin L, Pietiainen M, Auvinen P, et al. Subgingival microbiota in a population with and without cognitive dysfunction. J Oral Microbiology. 2021;13(1):9.

[49]. Laugisch O, Johnen A, Maldonado A, Ehmke B, Burgin W, Olsen I, et al. Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. J Alzheimers Dis. 2018;66(1):105-14.

[50]. Aragón F, Zea-Sevilla MA, Montero J, Sancho P, Corral R, Tejedor C, et al. Oral health in Alzheimer's disease: a multicenter case-control study. Clin Oral Investig. 2018;22(9):3061-70.

[51]. Bathini P, Foucras S, Dupanloup I, Imeri H, Perna A, Berruex JL, et al. Classifying dementia progression using microbial profiling of saliva. Alzheimers Dement-Diagn Assess Dis Monit. 2020;12(1):5.

[52]. Kobayashi N, Nagata T, Shinagawa S, Oka N, Shimada K, Shimizu A, et al. Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease. Biochem Biophys Res Commun. 2013;430(3):907-11.

[53]. Iwasaki M, Kimura Y, Yoshihara A, Ogawa H, Yamaga T, Sato M, et al. Oral health status in relation to cognitive function among older Japanese. Clinical and experimental dental research. 2015;1(1):3-9.

[54]. Li J, Broster LS, Jicha GA, Munro NB, Schmitt FA, Abner E, et al. A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging. Alzheimer's research & therapy. 2017;9:1-10.

[55]. Moriya S, Tei K, Toyoshita Y, Koshino H, Inoue N, Miura H. Relationship between periodontal status and intellectual function among community‐dwelling elderly persons. Gerodontology. 2012;29(2):e368-e74.

[56]. Naorungroj S, Slade G, Beck J, Mosley T, Gottesman R, Alonso A, et al. Cognitive decline and oral health in middle-aged adults in the ARIC study. Journal of Dental Research. 2013;92(9):795-801.

[57]. Bartold PM, Van Dyke TE. An appraisal of the role of specific bacteria in the initial pathogenesis of periodontitis. Wiley Online Library; 2019. p. 6-11.

[58]. Maitre Y, Micheneau P, Delpierre A, Mahalli R, Guerin M, Amador G, et al. Did the brain and oral microbiota talk to each other? A review of the literature. Journal of clinical medicine. 2020;9(12):3876.

[59]. Mao S, Huang C-P, Lan H, Lau H-G, Chiang C-P, Chen Y-W. Association of periodontitis and oral microbiomes with Alzheimer’s disease: A narrative systematic review. Journal of Dental Sciences. 2022.

[60]. Sureda A, Daglia M, Castilla SA, Sanadgol N, Nabavi SF, Khan H, et al. Oral microbiota and Alzheimer’s disease: Do all roads lead to Rome? Pharmacological research. 2020;151:104582.

[61]. Yang I, Arthur RA, Zhao L, Clark J, Hu Y, Corwin EJ, et al. The oral microbiome and inflammation in mild cognitive impairment. Experimental Gerontology. 2021;147:111273.

[62]. Liu X-X, Jiao B, Liao X-X, Guo L-N, Yuan Z-H, Wang X, et al. Analysis of salivary microbiome in patients with Alzheimer’s disease. Journal of Alzheimer's Disease. 2019;72(2):633-40.

[63]. Maitre Y, Mahalli R, Micheneau P, Delpierre A, Amador G, Denis F. Evidence and therapeutic perspectives in the relationship between the oral microbiome and Alzheimer’s disease: a systematic review. International Journal of Environmental Research and Public Health. 2021;18(21):11157.

[64]. François M, Bull CF, Fenech MF, Leifert WR. Current state of saliva biomarkers for aging and Alzheimer's disease. Current Alzheimer Research. 2019;16(1):56-66.

[65]. Gleerup HS, Hasselbalch SG, Simonsen AH. Biomarkers for Alzheimer’s disease in saliva: a systematic review. Disease markers. 2019;2019.

Cite this article

Piao,Q. (2023). Role of oral microbiota in Alzheimer’s disease: A systematic review of clinical studies. Theoretical and Natural Science,8,200-213.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 2nd International Conference on Modern Medicine and Global Health

Conference website: https://www.icmmgh.org/

ISBN：978-1-83558-111-7(Print) / 978-1-83558-112-4(Online)

Conference date: 5 January 2024

Editor：Mohammed JK Bashir

Series: Theoretical and Natural Science

Volume number: Vol.8

ISSN：2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).